BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21952274)

  • 1. Commentary: bevacizumab and erlotinib with chemoradiation for head and neck cancer.
    Burtness B
    Cancer J; 2011; 17(5):273-5. PubMed ID: 21952274
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined modality treatment with chemotherapy, radiation therapy, bevacizumab, and erlotinib in patients with locally advanced squamous carcinoma of the head and neck: a phase II trial of the Sarah Cannon oncology research consortium.
    Hainsworth JD; Spigel DR; Greco FA; Shipley DL; Peyton J; Rubin M; Stipanov M; Meluch A
    Cancer J; 2011; 17(5):267-72. PubMed ID: 21952273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ preservation for advanced head and neck cancer concomitant chemoradiation.
    Brockstein B
    Cancer Treat Res; 2003; 114():235-48. PubMed ID: 12619544
    [No Abstract]   [Full Text] [Related]  

  • 4. The never-ending story: finding a role for neoadjuvant chemotherapy in the management of head and neck cancer.
    Garden AS
    J Clin Oncol; 2014 Sep; 32(25):2685-6. PubMed ID: 25049324
    [No Abstract]   [Full Text] [Related]  

  • 5. Does DeCIDE give a decisive answer against induction chemotherapy in head and neck cancers?
    Chakraborty S; Patil VM
    J Clin Oncol; 2015 Mar; 33(8):967. PubMed ID: 25667296
    [No Abstract]   [Full Text] [Related]  

  • 6. A new look at induction chemotherapy in locally advanced head and neck cancer.
    Vermorken JB
    Oncologist; 2010; 15 Suppl 3():1-2. PubMed ID: 21036881
    [No Abstract]   [Full Text] [Related]  

  • 7. Synchronous chemoradiation for squamous carcinomas.
    Tobias JS; Ball D
    BMJ; 2001 Apr; 322(7291):876-8. PubMed ID: 11302885
    [No Abstract]   [Full Text] [Related]  

  • 8. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
    Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
    Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reply to s. Chakraborty et al.
    Cohen EE; Kocherginsky M; Karrison T; Seiwert TY; Haraf DJ; Brockstein B; Vokes EE
    J Clin Oncol; 2015 Mar; 33(8):968. PubMed ID: 25667282
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction chemotherapy for squamous cancer of the head and neck.
    Kies MS
    Curr Oncol Rep; 2007 Mar; 9(2):129-33. PubMed ID: 17288879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is induction chemotherapy the new standard in organ preservation treatment for locally advanced head and neck cancer in 2010?
    Porceddu SV
    Asia Pac J Clin Oncol; 2010 Jun; 6(2):75-6. PubMed ID: 20565417
    [No Abstract]   [Full Text] [Related]  

  • 12. Looking beyond the CRT paradigm: why induction chemotherapy is worthy of pursuit.
    Adkins D; Ley J; Michel L; Wildes TM; Thorstad W; Rich J; Nussenbaum B
    Oral Oncol; 2015 Feb; 51(2):103-4. PubMed ID: 25497105
    [No Abstract]   [Full Text] [Related]  

  • 13. Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial.
    Merlano M; Russi EG; Numico G; Colantonio I; Garrone O; Pelissero A; Granetto C; Gasco M; Di Costanzo G; Heouaine A; Vigna Taglianti R; Cipolat M
    Radiother Oncol; 2005 May; 75(2):193-6. PubMed ID: 16086909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy in head and neck cancer.
    Armand JP; Couteau C
    Eur J Cancer; 1995; 31A(5):819-22. PubMed ID: 7640066
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant chemotherapy for resectable squamous cell carcinoma of the head and neck. Report on Intergroup Study 0034.
    Hong WK
    Int J Radiat Oncol Biol Phys; 1992; 23(4):885-6. PubMed ID: 1618679
    [No Abstract]   [Full Text] [Related]  

  • 16. Integrating novel agents into the curative treatment of head and neck cancer.
    Haddad R; Allen A; Wirth L; Tishler R; Posner M
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):157-9. PubMed ID: 16445367
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy in locally advanced head and neck cancer: a critical reappraisal.
    Jassem J; Bartelink H
    Cancer Treat Rev; 1995 Sep; 21(5):447-62. PubMed ID: 8556718
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimizing approaches to head and neck cancer. Metastatic head and neck cancer: new options.
    Licitra L; Locati LD; Bossi P
    Ann Oncol; 2008 Sep; 19 Suppl 7():vii200-3. PubMed ID: 18790949
    [No Abstract]   [Full Text] [Related]  

  • 19. Future directions in the chemotherapy of head and neck cancer.
    Grunberg SM
    Am J Clin Oncol; 1985 Feb; 8(1):51-4. PubMed ID: 2581435
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of chemotherapy in the treatment of head and neck cancer.
    Inuyama Y; Fukuda S; Furuta Y; Yagi K; Nagahashi T; Chida E; Shirato H; Fujii M; Kanzaki J
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():52-9. PubMed ID: 9210888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.